Skip to main content
Heather Nichols, MD, Pediatrics, Oxnard, CA

HeatherFNicholsMDFAAP (She/Her)

Pediatrics Oxnard, CA

Pediatrician at Coastal Pediatric Medical Group

Dr. Nichols is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nichols' full profile

Already have an account?

  • Office

    451 W Gonzales Rd
    Ste 340
    Oxnard, CA 93036
    Phone+1 805-983-3900
    Fax+1 805-983-3887

Education & Training

  • Brown University
    Brown UniversityResidency, Pediatrics, 2003 - 2006
  • Drexel University College of Medicine
    Drexel University College of MedicineClass of 2003
  • Case Western Reserve University
    Case Western Reserve UniversityMA, Bioethics, 1997 - 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2006 - 2026
  • RI State Medical License
    RI State Medical License 2005 - 2006
  • American Board of Pediatrics Pediatrics

Press Mentions

  • Vertex and CRISPR Therapeutics Announce Global Exa-Cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022
    Vertex and CRISPR Therapeutics Announce Global Exa-Cel Regulatory Submissions for Sickle Cell Disease and Beta Thalassemia in 2022September 27th, 2022
  • Vertex and CRISPR Therapeutics Present New Data in 22 Patients with Greater Than 3 Months Follow-up Post-Treatment with Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at European Hematology Association Annual Meeting
    Vertex and CRISPR Therapeutics Present New Data in 22 Patients with Greater Than 3 Months Follow-up Post-Treatment with Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at European Hematology Association Annual MeetingJune 11th, 2021
  • CRISPR Therapeutics Receives Grant to Advance in Vivo CRISPR/Cas9 Gene Editing Therapies for HIV
    CRISPR Therapeutics Receives Grant to Advance in Vivo CRISPR/Cas9 Gene Editing Therapies for HIVDecember 7th, 2020
  • Join now to see all